Stimulation of prolactin secretion by neuroleptics in rats with medial basal hypothalamic lesions

Cecilia Cheung, Anne C. Neill, Richard I. Weiner

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The ability of dopamine receptor antagonists to stimulate prolactin release in rats with medial basal hypothalamic lesions was investigated. Starting levels of prolactin were elevated to approximately 400 ng/ml in animals in which the tuberoinfundibular dopaminergic neurons were completely destroyed by the lesion. In lesioned animals, chlorproma zine administration at doses of 0.1 and 5 mg/kg induced a further 2- to 3-fold significant increase in plasma prolactin levels. The incubation of anterior pituitaries from lesioned animals with 10-6 M chlorpromazine had no effect on prolactin secretion, thereby eliminating the possibility that chlorpromazine itself stimulates prolactin release from the anterior pituitary. A similar increase in plasma prolactin in lesioned rats was also observed with the potent dopamine antagonist d-butaclamol (1 mg/kg). The effect was stereospecific since the inactive isomer d-butaclamol did not produce any change in the circulating levels of prolactin. Pimozide, another dopaminergic antagonist, was ineffective in inducing a further increase in prolactin in lesioned rats when 0.63 mg/kg was used. However, at a 10-fold lower concentration (0.063 mg/kg), pimozide stimulated a significant increase in prolactin in lesioned rats. The involvement of an α-adrenergic mechanism was ruled out by the inability of phentolamine (2.5 mg/kg) to increase prolactin secretion. These data suggest that dopaminergic antagonists can further increase prolactin levels in medial basal hypothalamic-lesioned rats possibly by blocking the inhibitory action of dopamine from nonhypothalamic sources, or by releasing a substance which possesses prolactin-releasing activity.

Original languageEnglish (US)
Pages (from-to)370-374
Number of pages5
JournalNeuroendocrinology
Volume32
Issue number6
DOIs
StatePublished - 1981
Externally publishedYes

Fingerprint

Prolactin
Antipsychotic Agents
Dopamine Antagonists
Butaclamol
Pimozide
Chlorpromazine
Phentolamine
Dopaminergic Neurons
Adrenergic Agents
Dopamine

Keywords

  • Hypothalamic lesions
  • Neuroleptics
  • Prolactin

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Cellular and Molecular Neuroscience
  • Endocrine and Autonomic Systems
  • Neuroscience(all)

Cite this

Stimulation of prolactin secretion by neuroleptics in rats with medial basal hypothalamic lesions. / Cheung, Cecilia; Neill, Anne C.; Weiner, Richard I.

In: Neuroendocrinology, Vol. 32, No. 6, 1981, p. 370-374.

Research output: Contribution to journalArticle

Cheung, Cecilia ; Neill, Anne C. ; Weiner, Richard I. / Stimulation of prolactin secretion by neuroleptics in rats with medial basal hypothalamic lesions. In: Neuroendocrinology. 1981 ; Vol. 32, No. 6. pp. 370-374.
@article{ea18535a9072477495a200b17c43af99,
title = "Stimulation of prolactin secretion by neuroleptics in rats with medial basal hypothalamic lesions",
abstract = "The ability of dopamine receptor antagonists to stimulate prolactin release in rats with medial basal hypothalamic lesions was investigated. Starting levels of prolactin were elevated to approximately 400 ng/ml in animals in which the tuberoinfundibular dopaminergic neurons were completely destroyed by the lesion. In lesioned animals, chlorproma zine administration at doses of 0.1 and 5 mg/kg induced a further 2- to 3-fold significant increase in plasma prolactin levels. The incubation of anterior pituitaries from lesioned animals with 10-6 M chlorpromazine had no effect on prolactin secretion, thereby eliminating the possibility that chlorpromazine itself stimulates prolactin release from the anterior pituitary. A similar increase in plasma prolactin in lesioned rats was also observed with the potent dopamine antagonist d-butaclamol (1 mg/kg). The effect was stereospecific since the inactive isomer d-butaclamol did not produce any change in the circulating levels of prolactin. Pimozide, another dopaminergic antagonist, was ineffective in inducing a further increase in prolactin in lesioned rats when 0.63 mg/kg was used. However, at a 10-fold lower concentration (0.063 mg/kg), pimozide stimulated a significant increase in prolactin in lesioned rats. The involvement of an α-adrenergic mechanism was ruled out by the inability of phentolamine (2.5 mg/kg) to increase prolactin secretion. These data suggest that dopaminergic antagonists can further increase prolactin levels in medial basal hypothalamic-lesioned rats possibly by blocking the inhibitory action of dopamine from nonhypothalamic sources, or by releasing a substance which possesses prolactin-releasing activity.",
keywords = "Hypothalamic lesions, Neuroleptics, Prolactin",
author = "Cecilia Cheung and Neill, {Anne C.} and Weiner, {Richard I.}",
year = "1981",
doi = "10.1159/000123188",
language = "English (US)",
volume = "32",
pages = "370--374",
journal = "Neuroendocrinology",
issn = "0028-3835",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Stimulation of prolactin secretion by neuroleptics in rats with medial basal hypothalamic lesions

AU - Cheung, Cecilia

AU - Neill, Anne C.

AU - Weiner, Richard I.

PY - 1981

Y1 - 1981

N2 - The ability of dopamine receptor antagonists to stimulate prolactin release in rats with medial basal hypothalamic lesions was investigated. Starting levels of prolactin were elevated to approximately 400 ng/ml in animals in which the tuberoinfundibular dopaminergic neurons were completely destroyed by the lesion. In lesioned animals, chlorproma zine administration at doses of 0.1 and 5 mg/kg induced a further 2- to 3-fold significant increase in plasma prolactin levels. The incubation of anterior pituitaries from lesioned animals with 10-6 M chlorpromazine had no effect on prolactin secretion, thereby eliminating the possibility that chlorpromazine itself stimulates prolactin release from the anterior pituitary. A similar increase in plasma prolactin in lesioned rats was also observed with the potent dopamine antagonist d-butaclamol (1 mg/kg). The effect was stereospecific since the inactive isomer d-butaclamol did not produce any change in the circulating levels of prolactin. Pimozide, another dopaminergic antagonist, was ineffective in inducing a further increase in prolactin in lesioned rats when 0.63 mg/kg was used. However, at a 10-fold lower concentration (0.063 mg/kg), pimozide stimulated a significant increase in prolactin in lesioned rats. The involvement of an α-adrenergic mechanism was ruled out by the inability of phentolamine (2.5 mg/kg) to increase prolactin secretion. These data suggest that dopaminergic antagonists can further increase prolactin levels in medial basal hypothalamic-lesioned rats possibly by blocking the inhibitory action of dopamine from nonhypothalamic sources, or by releasing a substance which possesses prolactin-releasing activity.

AB - The ability of dopamine receptor antagonists to stimulate prolactin release in rats with medial basal hypothalamic lesions was investigated. Starting levels of prolactin were elevated to approximately 400 ng/ml in animals in which the tuberoinfundibular dopaminergic neurons were completely destroyed by the lesion. In lesioned animals, chlorproma zine administration at doses of 0.1 and 5 mg/kg induced a further 2- to 3-fold significant increase in plasma prolactin levels. The incubation of anterior pituitaries from lesioned animals with 10-6 M chlorpromazine had no effect on prolactin secretion, thereby eliminating the possibility that chlorpromazine itself stimulates prolactin release from the anterior pituitary. A similar increase in plasma prolactin in lesioned rats was also observed with the potent dopamine antagonist d-butaclamol (1 mg/kg). The effect was stereospecific since the inactive isomer d-butaclamol did not produce any change in the circulating levels of prolactin. Pimozide, another dopaminergic antagonist, was ineffective in inducing a further increase in prolactin in lesioned rats when 0.63 mg/kg was used. However, at a 10-fold lower concentration (0.063 mg/kg), pimozide stimulated a significant increase in prolactin in lesioned rats. The involvement of an α-adrenergic mechanism was ruled out by the inability of phentolamine (2.5 mg/kg) to increase prolactin secretion. These data suggest that dopaminergic antagonists can further increase prolactin levels in medial basal hypothalamic-lesioned rats possibly by blocking the inhibitory action of dopamine from nonhypothalamic sources, or by releasing a substance which possesses prolactin-releasing activity.

KW - Hypothalamic lesions

KW - Neuroleptics

KW - Prolactin

UR - http://www.scopus.com/inward/record.url?scp=0019486908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019486908&partnerID=8YFLogxK

U2 - 10.1159/000123188

DO - 10.1159/000123188

M3 - Article

C2 - 6165920

AN - SCOPUS:0019486908

VL - 32

SP - 370

EP - 374

JO - Neuroendocrinology

JF - Neuroendocrinology

SN - 0028-3835

IS - 6

ER -